文献速递流行病学与生物统计

无进展生存期与总生存期的联合建模及相关性度量计算

Joint modeling of progression-free and overall survival and computation of correlation measures.
PubMed 文献 · Stat Med · 2019-07-04

本文在多状态模型中,将无进展生存期与总生存期的联合分布表示为转移概率的函数,无需copula或潜在事件时间假设,且允许非马尔可夫模型。以Pearson相关系数为例,在参数框架下给出闭式公式与统计推断,并应用于一项大型乳腺癌随机临床试验。

要点

  • 联合分布由多状态模型转移概率直接导出,无需copula或潜在事件时间假设。
  • 模型允许非马尔可夫,参数框架下给出Pearson相关系数的闭式公式与统计推断。
  • 方法完全通用,可推广至其他依赖度量,并讨论非参数推断扩展。

核心结论

  • 在多状态模型中无需copula或潜在事件时间假设即可导出无进展生存期与总生存期的联合分布,并计算Pearson相关系数等依赖度量。

研究设计与样本

  • 方法学论文,基于多状态模型推导联合分布,以大型乳腺癌随机临床试验进行示例分析。

主要发现

  • 联合分布可表示为转移概率的函数,模型允许非马尔可夫。
  • 在参数框架下给出Pearson相关系数的闭式公式与统计推断,建模框架较现有方法更简约。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this paper, we derive the joint distribution of progression-free and overall survival as a function of transition probabilities in a multistate model. No assumptions on copulae or latent event times are needed and the model is allowed to be non-Markov. From the joint distribution, statistics of interest can then be computed. As an example, we provide closed formulas and statistical inference for Pearson's correlation coefficient between progression-free and overall survival in a parametric framework. The example is inspired by recent approaches to quantify the dependence between progression-free survival, a common primary outcome in Phase 3 trials in oncology and overall survival. We complement these approaches by providing methods of statistical inference while at the same time working within a much more parsimonious modeling framework. Our approach is completely general and can be applied to other measures of dependence. We also discuss extensions to nonparametric inference. Our analytical results are illustrated using a large randomized clinical trial in breast cancer.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Meller M, Beyersmann J, Rufibach K, et al. Joint modeling of progression-free and overall survival and computation of correlation measures. Stat Med. 2019. PMID: 31273817. doi:10.1002/sim.8295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。